Dysplastic Nevus Syndrome

WEDNESDAY, Nov. 20, 2024 -- Teledermoscopy has high accuracy for detecting skin cancers, according to a research letter published online Nov. 9 in the Journal of the American Academy of Dermatology . Jenne P. Ingrassia, from New York Medical College in Valhalla, and colleagues conducted a prospective diagnostic accuracy study to compare the accuracy of telemedicine-based skin cancer detection to in-person evaluations. In addition, off-label use of Nevisense, a device to assess melanocytic skin lesions suspicious for melanoma for use in dermatologists' offices, was evaluated for improving accuracy of teledermoscopy. A total of 147 participants with 375 self-identified skin lesions were assessed. The researchers found that 97 percent of the skin lesions were benign. The most common diagnoses were seborrheic keratosis, common melanocytic nevus, solar lentigo, other, and hemangioma (38, 19, 10, 8, and 4 percent, respectively). Overall, 13 participants had a malignant neoplasm, with two melanomas. Eleven of 13 skin cancers were detected in face-to-face examination, with accuracy of 93 percent. The TeleTeam detected 11/13 skin cancers with clinical photos and dermoscopy alone (accuracy of 91 percent). The TeleTeam detected 12/13 skin cancers with Nevisense, but due to lower specificity, a high prevalence of benign lesions, and the rarity of atypical nevi and early-stage melanomas, accuracy decreased to 83 percent. Overall, 89 percent of participants who completed a postintervention questionnaire agreed or strongly agreed that they would feel more at ease having their worrisome spot examined by a teledermatologist versus not examined. "Our results support the potential utility of teledermoscopy to safely triage patient- and primary-care clinician-identified skin lesions for in-person evaluation," the authors write.

Eye Cancer Treatment: Introduction Eye cancer, also known as ocular cancer, occurs in the eye of children and adults. It is in the form of a tumor that starts in and around the eye. There are two types of eye cancer. Primary intraocular cancer starts in the eyeballs. Primary intraocular melanoma is a highly common type, followed by primary intraocular lymphoma. Retinoblastoma is a highly common form of primary intraocular cancer that mostly occurs in children. Secondary intraocular cancer is a metastatic cancer that starts from other parts of the body and spreads to the eyes. Secondary intraocular cancer is more common than primary intraocular cancer, and it is often metastatic form of breast and lung cancers. Risk of prevalence of an eye cancer is higher in Caucasians than in people from Asia or African Americans. People with certain inherited conditions, such as dysplastic nevus syndrome, BAP1 cancer syndrome, are more prone to suffer from eye cancer. Request Brochure of Report - Eye Cancer Treatment: Introduction Eye cancer, also known as ocular cancer, occurs in the eye of children and adults. It is in the form of a tumor that starts in and around the eye. There are two types of eye cancer. Primary intraocular cancer starts in the eyeballs. Primary intraocular melanoma is a highly common type, followed by primary intraocular lymphoma. Retinoblastoma is a highly common form of primary intraocular cancer that mostly occurs in children. Secondary intraocular cancer is a metastatic cancer that starts from other parts of the body and spreads to the eyes. Secondary intraocular cancer is more common than primary intraocular cancer, and it is often metastatic form of breast and lung cancers. Risk of prevalence of an eye cancer is higher in Caucasians than in people from Asia or African Americans. People with certain inherited conditions, such as dysplastic nevus syndrome, BAP1 cancer syndrome, are more prone to suffer from eye cancer. Request for Analysis of COVID-19 Impact on Eye Cancer Treatment Market – Orbit Tumor to be Highly Attractive Segment In terms of type, the global eye cancer treatment market can be classified into eyelid tumor, corneal cancer, uveal melanoma, and orbital tumor Corneal cancer is a squamous cell carcinoma of the conjunctiva, which is a malignant tumor that occurs in the lining of the eyeballs and eyelids. An orbital tumor occurs in the orbit, which is the bony socket containing an eye. Orbit tumor could be malignant or benign and can be either primary or metastatic. Rhabdomyosarcoma and retinoblastoma are the two most life threatening orbital tumors. Retinoblastoma is a malignant tumor that starts from the retina. It is most common in children and often passed on from the parents. Eyelid tumor occurs in sebaceous gland known as the carcinoma of the eyelid. Uveal melanoma is a primary malignant tumor, which is a highly common eye cancer. Pre book Eye Cancer Treatment Market Report at Laser Therapy to be Highly Attractive Segment Based on treatment, the global eye cancer treatment market can be categorized into surgery, radiation therapy, laser therapy, chemotherapy, and others The laser therapy segment is estimated to account for a notable share during the forecast period owing to the high number of laser procedures for the treatment of eye cancer Hospitals to be Highly Lucrative Segment Based on end-user, the global eye cancer treatment market can be categorized into hospitals, clinics, and ambulatory surgical centers The hospitals segment is likely to account for a major share of the global eye cancer treatment market by 2031 due to an increase in consultation of patients in hospitals Top of Form Ask for Discount : Key Players Operating in Global Eye Cancer Treatment Market The global eye cancer treatment market is semi-consolidated, with the presence of international and local players. Key players operating in the global eye cancer treatment market are: Novartis AG Spectrum Pharmaceuticals, Inc. GlaxoSmithKline plc Bayer AG Amgen, Inc. Takeda Pharmaceuticals Company Limited Eli Lilly and Company AstraZeneca F. Hoffmann-La Roche Ltd. Janssen Global Services, LLC Sanofi AbbVie, Inc. Pfizer, Inc. Merck & Co., Inc. Bristol-Myers Squibb Company Oncomed Pharmaceuticals About Us Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision. Contact Mr. Rohit Bhisey Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: